FDA Inspection 753405 — Kramer Laboratories, Inc.

Kramer Laboratories, Inc. — FEI 1000113572

The FDA completed an inspection of Kramer Laboratories, Inc. on Nov 7, 2011 in Bridgewater, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 17 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 7, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Bridgewater, NJ (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
116821 CFR 211.34Consultant Records
1272021 CFR 1.225Not registered
1538221 CFR 111.8Written procedures - personnel qualifications
1540121 CFR 111.12(b)Personnel - quality control operations; identified
1545321 CFR 111.16Written procedures - cleaning
1545421 CFR 111.16Written procedures - pest control
1564121 CFR 111.453Written procedures - holding
1579721 CFR 111.553Written procedures - product complaint
1604221 CFR 111.503Written procedures - returned dietary supplement
356121 CFR 211.56(b)Written sanitation procedures lacking
356221 CFR 211.56(c)Written procedures lacking for use of pesticides etc.
363921 CFR 211.204Returned drug procedures in writing and followed
433621 CFR 211.150Written distribution procedure
434021 CFR 211.142Written warehousing procedures established/followed
438921 CFR 211.198(a)Procedures to be written and followed
900121 CFR 211.22(a)Lack of quality control unit

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.